IMMUCELL CORP /DE/ Quarterly Inventory, Net in USD from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.
Summary
Immucell Corp /De/ quarterly Inventory, Net history and growth rate from Q4 2010 to Q3 2024.
  • Immucell Corp /De/ Inventory, Net for the quarter ending September 30, 2024 was $7.46M, a 1.01% increase year-over-year.
Inventory, Net, Quarterly (USD)
Inventory, Net, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $7.46M +$74.8K +1.01% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $7.3M -$236K -3.14% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $7.15M +$821K +13% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $7.81M +$1.77M +29.4% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 $7.39M +$2.07M +38.9% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $7.54M +$2.93M +63.7% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $6.33M +$2.89M +84.2% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $6.04M +$2.95M +95.4% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $5.32M +$2.65M +99.4% Sep 30, 2022 10-Q 2022-11-21
Q2 2022 $4.6M +$2.18M +90.1% Jun 30, 2022 10-Q/A 2022-11-21
Q1 2022 $3.44M +$1.31M +61.9% Mar 31, 2022 10-Q/A 2022-11-21
Q4 2021 $3.09M +$997K +47.7% Dec 31, 2021 10-K 2023-03-29
Q3 2021 $2.67M +$576K +27.6% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $2.42M +$527K +27.9% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $2.12M +$524K +32.8% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $2.09M -$426K -16.9% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $2.09M -$590K -22% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $1.89M -$599K -24% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 $1.6M -$438K -21.5% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $2.52M +$187K +8% Dec 31, 2019 10-K 2021-03-30
Q3 2019 $2.68M +$431K +19.2% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $2.49M +$656K +35.7% Jun 30, 2019 10-Q 2019-08-12
Q1 2019 $2.04M +$106K +5.49% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $2.33M +$282K +13.8% Dec 31, 2018 10-K 2020-03-27
Q3 2018 $2.25M -$482K -17.6% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 $1.84M -$779K -29.8% Jun 30, 2018 10-Q 2018-08-13
Q1 2018 $1.93M -$169K -8.05% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $2.05M -$77.2K -3.63% Dec 31, 2017 10-K 2019-03-22
Q3 2017 $2.73M +$966K +54.7% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $2.62M +$1.39M +113% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $2.1M +$1.12M +114% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $2.13M +$1.26M +144% Dec 31, 2016 10-K 2018-03-29
Q3 2016 $1.77M +$902K +104% Sep 30, 2016 10-Q 2016-11-10
Q2 2016 $1.23M +$583K +90.2% Jun 30, 2016 10-Q 2016-08-11
Q1 2016 $981K +$402K +69.5% Mar 31, 2016 10-Q 2016-05-11
Q4 2015 $870K -$75.5K -7.99% Dec 31, 2015 10-K 2017-03-30
Q3 2015 $864K -$175K -16.8% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $646K -$298K -31.6% Jun 30, 2015 10-Q 2015-08-13
Q1 2015 $579K -$369K -38.9% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $946K -$261K -21.6% Dec 31, 2014 10-K 2016-03-25
Q3 2014 $1.04M -$451K -30.3% Sep 30, 2014 10-Q 2014-11-12
Q2 2014 $944K -$629K -40% Jun 30, 2014 10-Q 2014-08-13
Q1 2014 $947K -$496K -34.3% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $1.21M -$442K -26.8% Dec 31, 2013 10-K 2015-03-26
Q3 2013 $1.49M -$309K -17.2% Sep 30, 2013 10-Q 2013-11-13
Q2 2013 $1.57M -$93.5K -5.61% Jun 30, 2013 10-Q 2013-08-13
Q1 2013 $1.44M -$140K -8.87% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $1.65M -$17.5K -1.05% Dec 31, 2012 10-K 2014-03-26
Q3 2012 $1.8M +$43K +2.45% Sep 30, 2012 10-Q 2012-11-13
Q2 2012 $1.67M +$27.5K +1.68% Jun 30, 2012 10-Q/A 2012-09-07
Q1 2012 $1.58M Mar 31, 2012 10-Q 2012-05-14
Q4 2011 $1.67M +$65.4K +4.09% Dec 31, 2011 10-K 2013-03-28
Q3 2011 $1.76M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 $1.64M Jun 30, 2011 10-Q 2011-08-15
Q4 2010 $1.6M Dec 31, 2010 10-K 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.